$4.10
0.051.23%
Last update: Oct 30, 4:00 PM
ImageneBio Inc (IMA) Stock Price, Quote, News & History
IMANASDAQ
ImageneBio shares rise after a $30 million private placement to advance IMG-007 development for atopic dermatitis and alopecia areata.
You can purchase shares of ImageneBio (NASDAQ:IMA) through any online brokerage.
Other companies in ImageneBio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
ImageneBio has a consensus price target of $20.00.
The stock price for ImageneBio (NASDAQ: IMA) is $4.1 last updated October 30, 2026 at 4:00 PM EDT.
There are no upcoming dividends for ImageneBio.
ImageneBio does not have any upcoming earnings scheduled.
There is no upcoming split for ImageneBio.
ImageneBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that...
